Quarterly report [Sections 13 or 15(d)]

Condensed Balance Sheets

v3.25.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 2,365,000 $ 3,951,000
Restricted cash 93,000 93,000
Prepaid expenses and other current assets 200,000 188,000
TOTAL ASSETS 2,658,000 4,232,000
Current liabilities    
Accounts payable 2,380,000 3,853,000
Accrued expenses 1,132,000 1,797,000
Warrant liability 126,000 252,000
Total Current Liabilities 3,638,000 5,902,000
Stockholders’ Deficit    
Convertible Preferred stock, par value $0.01, 15,000,000 shares authorized Series C - 96,230 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively 1,000 1,000
Common stock, par value $0.001, 250,000,000 shares authorized, 2,536,397 and 2,234,328 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively 3,000 2,000
Additional paid in capital 695,019,000 693,554,000
Accumulated deficit (696,003,000) (695,227,000)
Total Stockholders’ Deficit (980,000) (1,670,000)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $ 2,658,000 $ 4,232,000